269 related articles for article (PubMed ID: 25772104)
1. Genomic and post-genomic effects of anti-glaucoma drugs preservatives in trabecular meshwork.
Izzotti A; La Maestra S; Micale RT; Longobardi MG; Saccà SC
Mutat Res; 2015 Feb; 772():1-9. PubMed ID: 25772104
[TBL] [Abstract][Full Text] [Related]
2. Effects of benzalkonium chloride- or polyquad-preserved fixed combination glaucoma medications on human trabecular meshwork cells.
Ammar DA; Kahook MY
Mol Vis; 2011; 17():1806-13. PubMed ID: 21750606
[TBL] [Abstract][Full Text] [Related]
3. Effects of glaucoma medications and preservatives on cultured human trabecular meshwork and non-pigmented ciliary epithelial cell lines.
Ammar DA; Kahook MY
Br J Ophthalmol; 2011 Oct; 95(10):1466-9. PubMed ID: 21602479
[TBL] [Abstract][Full Text] [Related]
4. Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells.
Ammar DA; Noecker RJ; Kahook MY
Adv Ther; 2010 Nov; 27(11):837-45. PubMed ID: 20931366
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial damage in the trabecular meshwork of patients with glaucoma.
Izzotti A; Saccà SC; Longobardi M; Cartiglia C
Arch Ophthalmol; 2010 Jun; 128(6):724-30. PubMed ID: 20547950
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity of ocular anterior chamber tissues to oxidative damage and its relevance to the pathogenesis of glaucoma.
Izzotti A; Saccà SC; Longobardi M; Cartiglia C
Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5251-8. PubMed ID: 19516005
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo experimental studies on trabecular meshwork degeneration induced by benzalkonium chloride (an American Ophthalmological Society thesis).
Baudouin C; Denoyer A; Desbenoit N; Hamm G; Grise A
Trans Am Ophthalmol Soc; 2012 Dec; 110():40-63. PubMed ID: 23818734
[TBL] [Abstract][Full Text] [Related]
8. Ocular Surface Disease with BAK preserved Travoprost and Polyquaternium 1(Polyquad) preserved Travoprost.
Kumar S; Singh T; Ichhpujani P; Vohra S
Rom J Ophthalmol; 2019; 63(3):249-256. PubMed ID: 31687627
[No Abstract] [Full Text] [Related]
9. Gene and protein expression changes in human trabecular meshwork cells treated with transforming growth factor-beta.
Zhao X; Ramsey KE; Stephan DA; Russell P
Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4023-34. PubMed ID: 15505052
[TBL] [Abstract][Full Text] [Related]
10. Oxidative DNA damage in the human trabecular meshwork: clinical correlation in patients with primary open-angle glaucoma.
Saccà SC; Pascotto A; Camicione P; Capris P; Izzotti A
Arch Ophthalmol; 2005 Apr; 123(4):458-63. PubMed ID: 15824217
[TBL] [Abstract][Full Text] [Related]
11. Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies.
Baudouin C; Pisella PJ; Fillacier K; Goldschild M; Becquet F; De Saint Jean M; Béchetoille A
Ophthalmology; 1999 Mar; 106(3):556-63. PubMed ID: 10080214
[TBL] [Abstract][Full Text] [Related]
12. Increased resistance to oxidative DNA damage of trabecular meshwork cells by E. coli FPG gene transfection.
Foresta M; Frosina G; Sacca SC; Cartiglia C; Longobardi M; Izzotti A
Free Radic Res; 2011 Jul; 45(7):751-8. PubMed ID: 21561236
[TBL] [Abstract][Full Text] [Related]
13. Surface chemistry study of the interactions of pharmaceutical ingredients with human meibum films.
Georgiev GA; Yokoi N; Ivanova S; Krastev R; Lalchev Z
Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4605-15. PubMed ID: 22695955
[TBL] [Abstract][Full Text] [Related]
14. Effect of benzalkonium chloride on trabecular meshwork cells in a new in vitro 3D trabecular meshwork model for glaucoma.
Bouchemi M; Roubeix C; Kessal K; Riancho L; Raveu AL; Soualmia H; Baudouin C; Brignole-Baudouin F
Toxicol In Vitro; 2017 Jun; 41():21-29. PubMed ID: 28214551
[TBL] [Abstract][Full Text] [Related]
15. Effects of oxidative stress in trabecular meshwork cells are reduced by prostaglandin analogues.
Yu AL; Fuchshofer R; Kampik A; Welge-Lüssen U
Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4872-80. PubMed ID: 18971427
[TBL] [Abstract][Full Text] [Related]
16. Oxidative damage and autophagy in the human trabecular meshwork as related with ageing.
Pulliero A; Seydel A; Camoirano A; Saccà SC; Sandri M; Izzotti A
PLoS One; 2014; 9(6):e98106. PubMed ID: 24945152
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of AAV transduction in glaucoma-associated human trabecular meshwork cells.
Borrás T; Xue W; Choi VW; Bartlett JS; Li G; Samulski RJ; Chisolm SS
J Gene Med; 2006 May; 8(5):589-602. PubMed ID: 16506246
[TBL] [Abstract][Full Text] [Related]
18. In vitro effects of preserved and unpreserved antiglaucoma drugs on apoptotic marker expression by human trabecular cells.
Hamard P; Blondin C; Debbasch C; Warnet JM; Baudouin C; Brignole F
Graefes Arch Clin Exp Ophthalmol; 2003 Dec; 241(12):1037-43. PubMed ID: 14605906
[TBL] [Abstract][Full Text] [Related]
19. [Human trabecular cells and apoptosis: in vitro evaluation of the effect of betaxolol with or without preservative].
Hamard P; Debbasch C; Blondin C; Brignole F; Loison-Dayma K; Warnet JM; Baudouin C
J Fr Ophtalmol; 2002 Oct; 25(8):777-84. PubMed ID: 12471343
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of benzalkonium chloride toxicity in a human trabecular meshwork cell line and the protective role of preservative-free tafluprost.
Chang C; Zhang AQ; Kagan DB; Liu H; Hutnik CM
Clin Exp Ophthalmol; 2015 Mar; 43(2):164-72. PubMed ID: 25041649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
